Rocket Lab Stock at a Crossroads: Neutron Engine Milestone Meets 94% Volatility and 200-Day Support
Published on 07/16/2026 at 16:17 | Redaktion boerse-global.de
Rocket Lab’s Archimedes vacuum engine roared to life for nearly 5.5 minutes at NASA’s Stennis Space Center on July 13, passing a full-power test that brings the company’s Neutron rocket one step closer to a debut still scheduled for 2026. Yet the engineering success did little to slow the stock’s slide. Shares closed at €66.50 the day before the test and have continued to fall, touching €64.70 on Thursday as the broader growth-stock sell?off and a string of insider sales kept buyers on the sidelines.
The drop has been severe. Over the past seven trading sessions Rocket Lab has shed more than 10% of its value, and from the May record high of €133.80 it is now down more than 50%. The decline has brought the stock within striking distance of its 200?day moving average of €67.35 — a level that chart watchers regard as one of the most important support zones. On Wednesday, volume slumped to 15.2 million shares, roughly 38% below the daily average, suggesting many investors are waiting for a clearer direction.
A pre?planned insider sale and a $8 billion bet
Adding to the pressure, the Equatorial Trust — a family trust tied to CEO Peter Beck — sold roughly 3.28 million shares between July 6 and 8, netting about $286.4 million. The transactions were executed under a Rule 10b5?1 trading plan that the trust had put in place on March 27, allowing for the sale of up to 5 million shares for diversification, estate planning and philanthropic purposes. Beck himself has voluntarily surrendered 392,155 vested stock options, directing the freed?up capital to strategic research projects. After the recent sales, Beck still holds nearly 491,930 shares directly and the trust holds another 1.72 million indirectly — roughly 90% of his original stake, according to one market observer.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The insider sales coincided with Rocket Lab’s announcement that it will acquire Iridium Communications for $54 per share in cash and stock, a deal valued at about $8 billion that aims to combine Rocket Lab’s launch and satellite?building capabilities with Iridium’s global communication network. The market’s initial reaction was cautious: Piper Sandler initiated coverage on July 15 with a neutral rating and a $83 price target, joining a chorus of analysts who still see the stock as expensive even after the pullback. KeyBanc, however, raised its target on the strength of the Space Systems segment and progress on Neutron, while Morgan Stanley reaffirmed an overweight rating and a $105 target, boosting its bull?case scenario from $185 to $293 on the additional launch and connectivity potential that the Iridium tie?up opens up. The overall Wall Street consensus remains a “Strong Buy” with an average price target of roughly $113.43.
Operating records and a nod to extreme volatility
Operationally, the company is firing on all cylinders. First?quarter revenue hit a record $200 million, the backlog stands at $2.2 billion, and recent defense contracts underscore the pace of execution. For a Space Force mission, Rocket Lab launched a rocket within 16 hours and 42 minutes of notification — the fastest reaction time ever recorded for a Tactically Responsive Space (TacRS) mission — and completed satellite commissioning in 38 hours. The Victus Haze mission marked the first time a single prime contractor delivered a complete mission from design and building to launch and operation of the Pioneer spacecraft.
The market’s nervousness is also captured in a new financial product introduced by the Bank of Montreal on July 15: share?linked notes with a conditional annual coupon of 20.65%, paid monthly, as long as Rocket Lab’s stock stays above $41.675 — half of the $83.35 reference price. The fat coupon reflects the 94.13% annualised volatility that currently places Rocket Lab among the most volatile growth names.
With a 14?day relative strength index of 33.1, the stock is flirting with oversold territory, and the 30?day volatility reading of more than 92% underscores how skittish the market remains. The next catalyst is the second?quarter earnings report, expected on August 6. Analysts are forecasting a net loss of $0.07 per share on revenue of about $231.79 million. Until then, the stock’s fate will likely be decided by whether it can hold the 200?day moving average — and whether the operational momentum that has delivered record revenue and a successful engine test can finally outweigh the cloud of insider sales and an acquisition that investors are still digesting.
Ad
Rocket Lab Stock: New Analysis - 16 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
